Atai Beckley Inc. (ATAI) Financials

ATAI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 264.8 million 88.4 million
March 31, 2026 264.9 million 66.1 million
Dec. 31, 2025 310.5 million 88.5 million
Sept. 30, 2025 239.8 million 79.9 million

ATAI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -35.3 million 7.4 million
March 31, 2026 -21.1 million 5.4 million
Dec. 31, 2025 -48.3 million 4.9 million
Sept. 30, 2025 -28.6 million 3.3 million

ATAI Net Income

No data available :(

ATAI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 225.8 million - 1.9 million
March 31, 2026 230.8 million - 2.0 million
Dec. 31, 2025 256.0 million - 1.8 million
Sept. 30, 2025 114.6 million - 3.0 million

ATAI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
March 31, 2026 226.5 million
Dec. 31, 2025 222.1 million
Sept. 30, 2025 217.6 million

ATAI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 28.1 million 17.9 million 158000
March 31, 2026 - 17.4 million 14.3 million -
Dec. 31, 2025 101779 19.0 million 25.1 million -
Sept. 30, 2025 5.4 million 14.6 million 14.4 million -

ATAI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.7 million 215000
March 31, 2026 953999 167000
Dec. 31, 2025 1.1 million -
Sept. 30, 2025 749000 233000

ATAI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ATAI

Price: $7.26

52 week price:
3.27
7.26

Earnings Per Share: -2.85 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 1.5 million

Ebitda: 9.8 million

Market Capitalization: 2.7 billion

Links: